Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.
Have you ever wondered why winter and flu season always overlaps? People sneezing, coughing and catching fever are more commonly seen in colder months. According to the preliminary estimation of CDC (Centers for Disease Control and Prevention), the overall burden of influenza (flu) for 2021-2022 in the US alone had reached approximately 9 million flu illnesses, among which 4 million […]
Human immunodeficiency virus, also known as HIV, is a virus that targets the body’s immune system, and even leads to AIDS (acquired immunodeficiency syndrome) if not if not treated early and properly. One can take several measures to prevent it (avoid sharing the same needles or syringes with others, wear a condom during sex, etc.), yet once they are infected […]
Sexually transmitted diseases (STDs) or sexually transmitted infections (STIs) are major public health problems worldwide. There are more than 1 million cases of STIs worldwide every day. STIs impact a person’s reproductive healthand are associated with infertility, cancer, pregnancy. In particular, STIs could also greatly increase the risk of HIV infection. This article will combine official data to know more […]
WHO has considered Monkeypox diseases a pandemic type of Public Health Emergency in the USA and the whole world. The cases of Monkeypox disease were reported primarily in tropical areas of central and West Africa but a fast-moving latest outbreak of this viral infection is creating a startle globally. From the start of 2022 till September, more than 65,000 confirmed […]
COVID-19 has radically changed the landscape for POC and Rapid Testing. According to Data Bridge Market Research, the point-of-care testing (POCT) market was estimated to be USD 29 billion in 2021, and it is expected to reach up to USD 64.46 billion by 2029 (CAGR 10.5%). As POCT become more sophisticated in terms of quality, speed, and artificial intelligence features, […]